tiprankstipranks
BB Biotech (0JYO) (GB:0JYO)
:0JYO
UK Market

BB Biotech (0JYO) Financial Statements

Compare
3 Followers

BB Biotech Financial Overview

BB Biotech's market cap is currently CHF2.06B. The company's EPS TTM is CHF2.285; its P/E ratio is 16.45; and it has a dividend yield of 5.32%. BB Biotech is scheduled to report earnings on February 21, 2025, and the estimated EPS forecast is CHF―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Dec 21Dec 20Dec 19Dec 18
Income Statement
Total Revenue
Gross Profit-----
Operating Income
EBITDA-----
Net Income$ -357.81M$ -404.81M$ 691.17M$ 677.43M$ -471.34M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 3.05B$ 3.64B$ 3.96B$ 3.55B$ 3.09B
Total Debt$ 363.00M$ 355.00M$ 63.00M$ 150.00M$ 185.00M
Net Debt$ 363.00M$ 355.00M$ 63.00M$ 150.00M$ 185.00M
Total Liabilities$ 367.25M$ 360.59M$ 75.59M$ 161.59M$ 202.33M
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ 231.13M$ -94.79M$ 262.45M$ 215.02M$ 107.79M
Operating Cash Flow
Investing Cash Flow
Financing Cash Flow
Currency in USD

BB Biotech Earnings and Revenue History

BB Biotech Debt to Assets

BB Biotech Cash Flow

BB Biotech Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis